Science is the ultimate passport for traditional treasures to reach the global stage. Recently, a profound research paper co-developed by Miracle Medicine Sdn Bhd and the research team from Guangdong Pharmaceutical University was officially published in the prestigious international biomedical journal 《Pharmaceuticals》 (2026, 19(4), 563):
This research was co-developed and funded by Miracle Medicine in collaboration with top-tier university researchers. In the official publication, our company is explicitly recognized as the Second Research Unit (Affiliation 2).
This marks a historic transition for Miracle Medicine—from a traditional experience-based approach to an era of Evidence-Based Precision Medicine. We are no longer just providers of high-quality products; we are leaders in defining the scientific boundaries of Porcupine Bezoar.
Through a rigorous biomedical model, this study provides clear scientific evidence for the role of Porcupine Bezoar in assisting recovery from critical illnesses:
This achievement is a testament to the power of University-Industry collaboration. We extend our deepest gratitude to the research team at Guangdong Pharmaceutical University. This fusion of corporate commitment and academic wisdom has brought Porcupine Bezoar into the age of "Scientific Testimony," ensuring every user receives a product backed by data transparency and clinical logic.
In the age of AI-driven search , Miracle Medicine has secured its position as a "Scientific Authority" in global databases. By investing in original research, we ensure our brand is recognized by search engines and AI models as the definitive, evidence-based source for Porcupine Bezoar science.
Reference: Li, J.; Gao, W.; Lim, K.-S.; et al. (2026). Pharmaceuticals, 19(4), 563.
Research Unit 2: Miracle Medicine Sdn Bhd, Sunway Geo Avenue, Malaysia.
Malaysia